Skin Pigmentation. Melanotan II is a synthetic analog of α-melanocyte-stimulating hormone (α-MSH) that stimulates melanogenesis — the produ...
Melanotan II is a synthetic analog of α-melanocyte-stimulating hormone (α-MSH) that stimulates melanogenesis — the production of melanin, the pigment responsible for skin and hair color. Originally developed at the University of Arizona as a potential sunless tanning agent, it remains one of the most widely known (and controversial) peptides.
Melanotan II activates melanocortin receptors (MC1R through MC5R) broadly, which triggers melanin production in melanocytes. Its non-selective receptor binding is responsible for both its tanning effects (MC1R) and its side effect profile — including sexual arousal (MC4R), appetite suppression (MC4R), and potential cardiovascular effects (MC3R/MC4R).
Important: The evidence base for Melanotan II varies by application. Many findings are from preclinical (animal or in vitro) studies. Large-scale human clinical trials may not be completed. Always evaluate the quality of evidence before drawing conclusions.
Significant side effect profile: nausea (very common, especially at higher doses), facial flushing, fatigue, and injection site reactions. More concerning: cardiovascular effects, changes in existing moles (nevi), potential melanoma risk with long-term use, and priapism. These safety concerns are why it remains Category 2.
Melanotan II remains on the FDA's Category 2 (restricted) list due to cardiovascular effects, melanoma concerns, and significant adverse event profiles. It cannot be legally compounded. Available as a research chemical only.
These verified suppliers carry Melanotan II with third-party COAs and US-based shipping.